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ARTICLE
Homozygosity Haplotype Allows a Genomewide Search for the
Autosomal Segments Shared among Patients
Hitoshi Miyazawa,* Masaaki Kato,* Takuya Awata, Masakazu Kohda, Hiroyasu Iwasa,
Nobuyuki Koyama, Tomoaki Tanaka, Huqun, Shunei Kyo, Yasushi Okazaki, and Koichi Hagiwara
A promising strategy for identifying disease susceptibility genes for both single- and multiple-gene diseases is to search
patients’ autosomes for shared chromosomal segments derived from a common ancestor. Such segments are characterized
by the distinct identity of their haplotype. The methods and algorithms currently available have only a limited capability
for determining a high-resolution haplotype genomewide. We herein introduce the homozygosity haplotype (HH), a
haplotype described by the homozygous SNPs that are easily obtained from high-density SNP genotyping data. The HH
represents haplotypes of both copies of homologous autosomes, allowing for direct comparisons of the autosomes among
multiple patients and enabling the identiﬁcation of the shared segments. The HH successfully detected the shared
segments from members of a large family with Marfan syndrome, which is an autosomal dominant, single-gene disease.
It also detected the shared segments from patients with model multigene diseases originating with common ancestors
who lived 10–25 generations ago. The HH is therefore considered to be useful for the identiﬁcation of disease susceptibility
genes in both single- and multiple-gene diseases.
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Current genetic approaches focus on the identiﬁcation of
disease susceptibility genes (hereafter referred to as “dis-
ease genes”) by exploiting the cosegregation of the disease
phenotype over generations with a disease gene as well as
a set of polymorphic marker types in its neighborhood
(i.e., the haplotype). In a large family including multiple
patients with a speciﬁc disease, the disease gene is usually
derived from a single ancestor. On the basis of this as-
sumption, haplotype analysis1 or linkage analysis2 has
been used to ﬁnd the gene. In affected-sib-pair analysis, a
sib pair affected with the same disease is considered to
share the same disease gene, inherited from their parents.
The gene is searched for by looking at the genetic markers
shared by the pair.1,3 In whole-genome association studies,
researchers try to capture segments containing disease-risk
alleles derived from a limited number of very ancient an-
cestors where a haplotype block is the ultimate unit of
search.4–6 Because the haplotype contains the canonical
information for every approach, determination of the
haplotype is considered to greatly simplify the analyses.7
However, the haplotype is not easy to identify in diploid
organisms such as humans, because the genotypes of poly-
morphic markers are obtained as a mixture of those of the
two alleles. Althoughmanymethods have been developed
to reconstruct the haplotype,1,7–9 their capabilities are lim-
ited. It is currently not possible, at least on a genomewide
basis, to obtain haplotype information from an arbitrary
subject or to compare two unrelated subjects in order to
search for chromosomal segments sharing the same hap-
lotype. In this study, we introduce the homozygosity hap-
lotype (HH), which overcomes a part of this problem. The
HH is a form of haplotype described by the homozygous
SNPs, and, therefore, it is easily obtained genomewide.
Using a family affected with Marfan syndrome (MIM
154700) and patients with model multigene diseases, we
demonstrate how HH analysis allows the identiﬁcation of
the location of disease genes.
Material and Methods
Deﬁnition of Terms
Homozygosity haplotype (HH).—An HH is a haplotype described
by only homozygous SNPs and is obtained by the deletion of
heterozygous SNPs (ﬁg. 1Ai), leaving only the homozygous SNPs
(ﬁg. 1Aii). At this point, the haplotype of each chromosome is
uniquely determined, because all SNPs are homozygous (ﬁg.
1Aiii). Note that both copies of homologous autosomes have the
same HH over their entire length.
Comparable SNP (compSNP).—A compSNP is a SNP that is ho-
mozygous in two subjects (ﬁg. 1B). We can compare the HHs
between two subjects by use of the compSNPs (ﬁg. 1C).
Region with a conserved HH (RCHH).—An RCHH is a run of
compSNPs matched for allelic type, the genetic length of which
is longer than the cutoff value (ﬁg. 1C). An RCHH is bounded by
either a mismatched compSNP(s) or by the end(s) of an autosome.
The RCHHs shared by multiple subjects are the overlap of the
RCHHs for each subject pair (ﬁg. 1D).
Region from a common ancestor (RCA).—An RCA is an autosomal
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Figure 1. HH analysis. A, “A” denotes the major allelic type for each SNP. “B” denotes the minor allelic type for each SNP. B, Deﬁnition
of a compSNP. C, Deﬁnition of an RCHH. An RCHH has a genetic length longer than the cutoff value. D, The deﬁnitions of an RCHH
shared among multiple patients.
region where subjects share a chromosomal segment derived from
a common ancestor (i.e., a segment identical by descent) (ﬁg. 2A).
In an RCA, subjects share the same segment on one or both copies
of their homologous autosomes and thus share the same HH.
Conversely, when subjects have the HH in a region, it suggests
the presence of an RCA. Note that the RCA is unknown, and its
presence is merely predicted through the RCHHs (see the section
entitled “The RCHHs, False Negatives, Type A False Positives, and
Type B False Positives”).
The average genetic length of the RCAs decreases over gen-
erations. Figure 2B is a model pedigree with common ancestors
(A and B). Two descendants (M and N), who are m and n gen-
erations removed from their common ancestors, share the RCAs
derived from A and B. Assuming that the spouses (shown in gray
shapes in ﬁg. 2B) are not the descendants of A or B, then
is the ratio of the total genetic length of the A- or B-RCA(m,n)
derived RCA to the entire length of the autosomes. It is expressed
as
m12 m 1,np 0
3
RCA(m,n:m n)p mp 1,np 1 (1)
4{
mn22 otherwise.
A detailed description of the deduction of equation (1) is given
in appendix A. Note that is equal to 1, indicating thatRCA(1,0)
a parent and a child (i.e., , ) share the RCAs over themp 1 np 0
entire lengths of their autosomes.
Crossover Model and Data Analysis
We used the Haldane’s Poisson processmodel10 for the occurrence
of crossovers and performed all calculations on the basis of this
model. Information on SNPs used by the 500K GeneChips Map-
ping Array Set (Affymetrix) was summarized in the GeneChip
annotation ﬁles (4/13/2006 version; see Affymetrix Web site),
where, for each SNP, the genetic distance from the telomere of
the short arm of the chromosome was obtained by interpolation
from the sex-averaged data by deCODE Genetics.11 The genetic
length of an RCHH is the genetic distance between its bounding
compSNPs.
We restricted our analysis to a total of 492,554 SNPs that had
assigned dbSNP refIDs (see National Center for Biology Infor-
mation Web site). The computer programs were written in the C
programming language and were compiled by the GNU C com-
piler 4.0 (see the GNU Compiler Collection Web site). The pro-
gram is available from ourWeb site and from the SaitamaMedical
University Web site.
The RCHHs, False Negatives, Type A False Positives, and
Type B False Positives
When subjects who have common ancestors suffer from the same
disease, the RCAs are the candidate regions in which to look for
the disease gene. Because many RCAs are contained in the
RCHHs, we established an algorithm that detects the RCHHs,
thereby allowing us to identify the disease gene. As described, an
RCHH is deﬁned when a run of type-matched compSNPs is longer
than the cutoff value (ﬁg. 3A). Many RCHHs contain the RCAs;
however, some do not. We deﬁned three types of errors (ﬁg. 3B).
The false negatives are the RCAs that are not contained in the
RCHHs. The type A false positives are the RCHHs that do not
contain the RCAs. The type B false positives are the spaces be-
tween a containing RCHH and a contained RCA. The equations
to calculate each of these errors are given in appendix A. Before
the analysis, we calculated the ratios of the false negatives to the
total length of the RCAs and of the type A and type B false pos-
itives to the entire length of the autosomes for a range of cutoff
values, and we selected a value that minimizes the inﬂuence of
errors.
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Figure 2. The RCA. A, The deﬁnition of an RCA. Gray regions are
those derived from a single ancestral autosome from a single an-
cestor (segments identical by descent). A subject may have two
copies of the segments in case inbreeding exists. B, A model
pedigree. “A” and “B” denote the common ancestors. M and N are
m and n generations away from the common ancestors. Direct
offspring are shown by unﬁlled shapes. The spouse of each off-
spring is shown as a gray shape.
Figure 3. RCHHs, false negatives, type A false positives, and type
B false positives. A, Detection of an RCHH. An RCHH has a genetic
length longer than the cutoff value. B, Relationship of an RCHH
and an RCA. The RCAs are overlaid and shown by dark gray boxes,
and the RCHHs are shown by light gray boxes. Three types of errors
are deﬁned.
Human Subjects
This study was approved by the institutional review board of
Saitama Medical University. All DNA samples were puriﬁed from
peripheral blood drawn after written informed consent had been
obtained. A family that included multiple patients with Marfan
syndrome was genotyped, as were 46 unrelated subjects. In ad-
dition, the genotyping data from 45 unrelated Japanese subjects
who had been enrolled in the International HapMap project (see
International HapMap Web site) were obtained from the Affym-
etrix Web site (an average of 199,400 SNPs per subject had con-
ﬁdence values !.05).
Genotyping
Genomewide SNP genotypings were performed using the 500K
GeneChips Mapping Array Set (i.e., the GeneChip Human Map-
ping 250K Nsp Array plus the GeneChip Human Mapping 250K
Sty Array) (Affymetrix) or either of the two arrays. (Hereafter, the
500K GeneChips Mapping Array Sets will be abbreviated as “500k
GeneChips” and the GeneChip HumanMapping 250K Nsp Array
as “250k GeneChips.”) 500k GeneChips was used for the analysis
of the family with Marfan syndrome. 250k GeneChips was used
for the multigene disease simulation.
Pools of Subjects
In the multigene disease simulations, genotyping data of patients
who share an RCA at a speciﬁc position were constructed by
replacing that part of their genotyping data with the genotyping
data of a speciﬁc subject who acts as a common ancestor. The
length of the replaced segment (x, in centimorgans) was taken at
random from an exponential distribution with a probability den-
sity function of
lxf(x)p le ,
m
lp , (2)
100
where m is the age, in generations, of the common ancestor.
Statistical Analysis
The numbers of subjects who share an RCHH at a given position
on an autosome were compared between the patient pool and
the control pool. The assumption was made that
∗ ∗
ˆ ˆP  P1 2u p0
1 1∗ ∗
ˆ ˆP (1 P ) ( )n n1 2
has a standard normal distribution, where ,x 0.5∗ ∗1ˆ ˆP p P p1 2n 11
, , , and are the numbers of subjects shar-x 0.5 x x 0.5∗2 1 2ˆP p x x1 2n 1 n n 12 1 2
ing RCHHs in the patient pool and the control pool, respectively,
and and are the total numbers of subjects in the patientn n1 2
pool and the control pool, respectively. The P valuewas calculated
by

2x1
Pp e dx .22p
u0
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Figure 4. Accuracy of the GeneChip data. A, Pedigree of a family with Marfan syndrome. B, Relationship between the conﬁdence-value
cutoffs and the concordance ratios. C, Schematic presentation of the data in panel B. D, False negatives between two subjects in
generation III and the average ratio of the type A false positives and the type B false positives to the entire length of the autosomes
for all combinations of subjects were plotted for a range of RCHH cutoffs.
Results
Analysis of a Family with Marfan Syndrome
To investigate the utility of the HH in a family analysis,
we studied a family that hasmultiple patients withMarfan
syndrome. Marfan syndrome is an autosomal dominant
disease characterized by an abnormality in the connective
tissue. Mutations of either the ﬁbrillin-1 gene (FBN-1) on
15q21.1 or of the TGF-b type II receptor gene (TGFBR2)
on 3p24.2 are known to be the cause of this syndrome.12
The family had been studied, and six symptomatic mem-
bers and three asymptomatic carriers had a heterozygous
1879CrT (R627C) mutation in FBN-1 (ﬁg. 4A). Subject I-
1 is considered to be the common ancestor for the disease
gene. The questions we posed were as follows: (i) Could
the HH identify the region containing FBN-1 by the data
from six symptomatic members? and (ii) Could the HH
further narrow the region with the inclusion into the anal-
ysis of three asymptomatic carriers?
Before beginning our analysis, we checked the accuracy
of the genotyping data. Equation (1) indicates that a par-
ent and a child share the same HH along the entire length
of their autosomes. Therefore, the ratio of the number of
the matched compSNPs to the total number of compSNPs
indicates the accuracy of genotyping. We studied three
pairs: II-1 and III-4, II-3 and III-1, and II-5 and III-3. In a
GeneChip analysis, the genotyping result for each SNP is
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accompanied by a conﬁdence value; the smaller the con-
ﬁdence values, the more reliable the data. The concor-
dance ratios of the compSNPs in three parent-child pairs
for a range of conﬁdence-value cutoffs are shown in ﬁgure
4B and 4C. We chose a conﬁdence-value cutoff of .05.
Secondly, we determined the cutoff value for deﬁning
the RCHHs (hereafter, an “RCHH cutoff”). Figure 4D
shows the relationship of the RCHH cutoffs and three
types of errors. We chose 3.0 cM because it gave small
rates of type A and type B false positiveswith an acceptable
value for the false negatives.
We then analyzed six symptomatic patients. In ﬁgure
5, we present the result stepwise. Patients II-3 and III-1 are
a parent-child pair who share RCHHs over the entire
length of the autosomes (ﬁg. 5A). II-1 and II-2 are siblings
whose RCHHs occupy 81% of the autosomes (eq. [1] pre-
dicted 75%) (ﬁg. 5B). II-2 and III-1 are an aunt and nephew
whose RCHHs occupy 56% of the autosomes (eq. [1] pre-
dicted 50%) (ﬁg. 5C). III-2 and III-3 are ﬁrst cousins whose
RCHHs occupy 39% of the autosomes (eq. [1] predicted
25%) (ﬁg. 5D). The RCHHs conserved among all symp-
tomatic members contained 96% of the total length of the
RCA (calculated from table A1), and they did indeed con-
tain FBN-1 (ﬁg. 5E). The inclusion of asymptomatic car-
riers (II-4, II-5, and III-4) (see ﬁg. 4A) did further narrow
the RCHHs (ﬁg. 5F). These results demonstrate that HH
analysis is both efﬁcient and intuitive for identifying the
location of disease genes in a large family.
Simulation of a Multigene Disease
Each multigene disease has a speciﬁc genetic structure.
Some are considered to be a collection of single-gene dis-
eases of which the phenotypes are indistinguishable from
each other. In others, several genes working together are
required to produce symptoms.13 In either case, a subgroup
of patients may share a disease gene from a common
ancestor.
To investigate the utility of the HH in multigene dis-
eases, we investigated a model multigene disease (ﬁg. 6A).
Here, SNP rs16823424 (the 100,000th SNP on 500k
GeneChip) is the location of the disease gene. In this re-
gion, 15 patients share an RCA derived from a common
ancestor who lived 10 generations ago. The genotyping
data around rs16823424 in these 15 patients were replaced
with the genotyping data at the corresponding position
from a speciﬁc person who, in this analysis, acts as the
common ancestor (ﬁg. 6B). The lengths of the replace-
ments were taken at random from an exponential distri-
bution (eq. [2]: ). Therefore, comparison of twomp 10
patients corresponds with the situation in ﬁg.mp np 10
2B. The patient pool included these 15 subjects together
with 30 unrelated subjects (ﬁg. 6C). The control pool
consists of 45 unrelated Japanese samples obtained from
the Affymetrix Web site. Our aim was to identify the
rs16823424 region. The strategy was as follows. In step 1,
we divided autosomal regions into minute regions. In step
2, using the patient pool, we identiﬁed the HH shared by
the greatest number of subjects for each region (i.e., the
most common HH). We then concatenated the most com-
mon HHs for each region into a virtual HH for the entire
autosome. A virtual subject who has this virtual HH was
named “the representative” (step 1 in ﬁg. 6C). The subjects
were counted who shared the RCHHs with “the represen-
tative” in both the patient pool and the control pool for
each region (step 2 in ﬁg. 6C). Finally, the differences be-
tween the pools were expressed by P values. The candidate
region for the disease gene is the region that has the lowest
P value (i.e., the greatest log10(P) value) in the entire
autosome.
Before the analysis, we determined an appropriate
RCHH cutoff (ﬁg. 6D). Here, the false negatives were plot-
ted for several ages of common ancestors (the ages are
expressed by m and n). As the number of generations in-
creases, the length of the RCA shortens, increasing the
difﬁculty of its detection with increasingly high m and n
values. Because an RCHH cutoff of 5 cM was considered
suitable for , this value is used hereafter. Themp np 10
false negatives to the total length of the RCAs decreases
as we include more SNPs in the analysis. This will be dis-
cussed later.
We then performed the analysis. Figure 6E is a densi-
togram of the log10(P) value; the denser the areas are,
the higher the signiﬁcance. The rs16823424 region pro-
vided a log10(P) of 4.48, and was the only region with a
(i.e., ). The greatest log10(P) out- log (P) 1 3.0 P ! .00110
side of the rs16823424 region was 2.92, which provides
the background of the analysis.
Next, we investigated the detection limit. For eachnum-
ber from 7 to 15, we constructed 100 patient pools in
which that number of patients, out of 45, shared an RCA
at the rs16823424 region. When the number is !9, the
background value overwhelmed the signal in most of the
analyses (ﬁg. 6F). Therefore, 10 of 45 patients (22%) was
the detection limit of this analysis.
Detection of Multiple Targets and the Effect of Age of
Common Ancestors
Wenext simulated amultigene disease with three different
causative genes: one at rs16823424 (the 100,000th SNP on
500k GeneChips), one at rs4473885 (the 200,000th SNP),
and one at rs11200928 (the 300,000th SNP). The ages of
the common ancestors were , 20, and 25. Wemp np 15
generated 100 sets of 45 subjects. Subjects 1–15 had a
segment replaced with that of a speciﬁc person (the com-
mon ancestor) for a length taken at random from an ex-
ponential distribution corresponding to . Sub-mp np 15
jects 16–30 had a segment replaced corresponding to
. Subjects 31–45 had a segment replaced cor-mp np 20
responding to (ﬁg. 7A). The analysis was per-mp np 25
formed with an RCHH cutoff of 5.0 cM. Figure 7B dem-
onstrates the detection of three targets simultaneously.
The detection limits were 10 (22%) ( ), 13mp np 15
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Figure 5. Family analysis. Identiﬁcation of the candidate regions for the disease gene for a family with Marfan syndrome. The RCHHs
are shown in black, whereas the other autosomal regions are shown in gray. A, The RCHHs between a parent and child, indicated by
arrows, are shown. B, The RCHHs between siblings. C, The RCHHs between an aunt and nephew. D, The RCHHs between ﬁrst cousins.
E, The RCHHs for all symptomatic members. The FBN-1 gene is located in the RCHH (19.6 cM in length) indicated by a large arrow. F,
The RCHHs for all nine members (six symptomatic members and three asymptomatic carriers) who have a mutation in the FBN-1 gene.
(29%) ( ) and 13 (29%) ( ) of 45mp np 20 mp np 25
patients.
Discussion
In this study, we introduce HH analysis. Both copies of
the homologous autosomes have the same HH and thus
can be handled as if they were a single chromosome with
a single HH. This enables the direct comparison of the
autosomes between two individuals and thereby enables
a search for a shared ancestral segment.
Because HH analysis looks for the ancestral segments,
both dominant and recessive genes can be detected. The
analysis is nonparametric—that is, it does not require the
information from the pedigree. The patient pool contains
only affected subjects, and therefore information on pen-
etrance is not necessary. All these characteristics make the
design and the interpretation of analyses simple.
Another characteristic of HH analysis is the simplicity
of the algorithm, and therefore the calculation may be
performed on many personal computers. The calculation
for a family with Marfan syndrome that contains nine
subjects (ﬁg. 5) is completed in 6 s on our laptop computer.
The analysis composed of two pools containing 45 sub-
jects each (ﬁg. 6E) took 5 min. The calculation time is
proportional to the square of the number of subjects, and
thus analyses with a larger number of subjects are not
difﬁcult to perform.
We used the classical Haldane’s Poisson model for the
calculations. In an actual situation, the crossovers do not
occur randomly along the length of the autosomes. One
of the major causes of the deviation from the model is
Figure 6. Simulation of a multigene disease. A, The structure of a model multigene disease. In 15 patients, a causative mutation of
the gene at rs16823424 is derived from a common ancestor. In the remaining 30 patients, the mutation may be from a different ancestor,
or the mutations may occur in a different disease gene(s). B, Construction of a patient pool. Black bars indicate segments at the
rs16823424 region taken from the common ancestor. St p subject. C, Analysis procedure. D, The average ratios of the type A false
positives and the type B false positives to the entire length of the autosomes for all combinations of the subjects in the control pool.
The ratio of the false negatives to the total length of the RCAs for several values of m and n are simultaneously shown. E, Densitogram
of log10(P) value for each region of the autosomes. A region that is 2.92 cM in length and contains rs16823424 (indicated by a white
arrow) gave the greatest log10(P) value, 4.09. F, The distribution of log10(P) from the analyses using 100 patient pools for each
number of patients is shown as mean  SD. The highest background value is 2.92 (i.e., the greatest log10(P) value outside of the
rs16823424 region).
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Figure 7. Multiple targets and the effect of the numbers of generations. A, Structure of the disease. B, An example of simultaneous
detection of three regions. White arrows indicate the position of individual SNPs. A 2.56-cM-length region containing 100,000th SNP
on chromosome 3, a 0.94-cM-length region containing the 200,000th SNP on chromosome 6 and a 2.55-cM-length containing the
300,000th SNP on chromosome 10 present the greatest log10(P) values in their neighborhood, and the values were 4.09, 4.39, and
3.49, respectively. C, The distribution of log10(P) from the analyses using 100 patient pools. The graph is similar to ﬁg. 6F, and the
data for three targets (100,000th SNP, 200,000th SNP, and 300,000th SNP) are simultaneously shown. The highest background value
is 2.92.
crossover interference.14 However, the crossover interfer-
ence suppresses the production of short RCAs and favors
the RCHHs in detecting true RCAs, so we made no ad-
justments for crossover interference in our calculation. For
more-detailed discussion, see appendix A. If inbreeding
exists in the pedigree, the segments from the common
ancestor may be located on both copies of homologous
autosomes, as in subject 2 in ﬁg. 2A. This increases the
average size of the RCAs and reduces the false negative
rates. However, the rate of false positives may rise. The
detailed information on inbreeding that occurred in pre-
vious generations is most often unknown. The practical
approach to handling this is to calculate the false positives
by use of the actual genotyping data, as illustrated inﬁgure
6D, and to determine the RCHH cutoff. This compensates
for the lack of information on inbreeding.
The numbers of SNPs used in this study were not suf-
ﬁcient to detect ancestral segments with an age of m
(ﬁg. 6D). The number of type A false positives isn 1 30
reduced as the number of SNPs increases (ﬁg. 8). (The rate
of type B false positives is heavily dependent on the actual
genotyping data and thus was not plotted.) A larger num-
ber of SNPs will allow us to use a smaller RCHH cutoff.
Figure 8 suggests that the genotyping data of 1,000,000
SNPs may expand the range of analysis to .m n 1 60
In the model multigene diseases, we used the patient
pool containing 45 subjects. However, smaller numbers of
subjects worked ﬁne as well. For example, a pool of 18
subjects containing 6 subjects sharing an RCA clearly pro-
vided sufﬁcient signal, althoughwith a higher background
(data not shown).
The four major methods for the identiﬁcation of disease
genes are the haplotype analysis, the linkage analysis, the
sib-pair analysis and the whole-genome association stud-
ies.15 The former two methods target single-gene diseases
occurring in families (usually ), whereas the latterm n ! 6
two methods target both single-gene and multigene dis-
eases occurring in the general population. When m
, HH analysis does not work well. In fact, the HHn ! 3
cannot distinguish parents from children, as shown in
ﬁgure 5A, whereas haplotype analysis or linkage analysis
may be able to identify a disease gene from pedigrees com-
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Figure 8. The effect of the numbers of SNPs used and the target
generations of the analysis. The type A false positives were plotted
for a range of numbers of the SNPs genotyped. The false negatives
were plotted for a range of values.m n
posed of only two generations.16 For families containing
subjects with , HH analysis works well, as shownm n 3
in ﬁgure 5. HH analysis may provide an advantage when
where the haplotype analysis or the link-6m n 50
age analysis are difﬁcult to perform. HH analysis is con-
sidered applicable to sib-pair analysis, where one sib pair
provides 3/4 of the entire autosomes as shared regions (see
eq. [1]). One attractive application may be for affected-
relative-pair analyses.17 Equation (1) indicates that one
second-cousin pair may narrow the candidate autosomal
region to 1/16 of the entire length of the autosomes,
and three second-cousin pairs may narrow it further to
.3(1/16) p 1/4,096
The simulation results presented in this study suggest
that HH analysis demonstrates advantages and may com-
plement whole-genome association studies by detecting
genes for common diseases in the following situations. (1)
The target population is genetically isolated. (2) The rel-
ative risk of the disease gene is moderate to high, and thus
the frequencies of the disease-associated HH are expected
to be signiﬁcantly different between the patient pool and
the control pool. (3) The common ancestors who brought
the disease gene into the population are assumed to have
existed within the last several hundred years, thus en-
abling the detection of the RCAs as RCHHs. (4) The num-
ber of the common ancestors who brought the disease
gene was small, which limits the number of the disease-
associated HHs in the population, and thus the frequen-
cies of some of them may exceed the detection limit
shown in ﬁgures 6F and 7C. When these conditions are
met, the inclusion of only a few dozen patients may be
required to identify the location of the disease gene (ﬁgs.
6 and 7). However, the identiﬁed regions may be 1–3 cM
in length and require more-detailed investigation. Eth-
nically, geographically, or culturally isolated populations
may fulﬁll these requirements for many diseases. For ex-
ample, consider the French-Canadian population in
Quebec.18,19 It is known that two-thirds of the genetic pool
of the current population of 6 million people is derived
from only 2,600 settlers who arrived during the 17th cen-
tury (i.e., , given 20 years per generation). Themp np 20
causative genes for diseases with an incidence of 0.01
may be derived from only one or two dozen common
ancestors. In other words, the number of the disease-as-
sociated HH was limited to one or two dozen because of
the bottleneck effect caused by the immigration. If ran-
dom genetic drift is taken into consideration, some of the
disease-associated HH may exceed the detection limit of
29% in the patient pool (ﬁg. 7B). Therefore, moderate- to
high-risk genes for diseases with an incidence of 0.01 in
Quebec fulﬁlls all four requirements and is thereforeworth
studying by HH analysis, whether the gene is for a single-
gene disease or a multigene disease. If any one of the four
conditions is not met, HH analysis should not be consid-
ered a good choice. The selection of the target population
and the target disease are crucial.
In this study, we describe the introduction of the HH
and its applications. The HH is easy to obtain and the
results are intuitive. Although modern society promotes
the movement of people, many countries have a history
in which the transfer of people was politically or geo-
graphically limited. Patients with a speciﬁc disease clus-
tered in a geographical region therefore may inherit a
common ancestral disease gene. In such regions, HH anal-
ysis may provide a distinct beneﬁt. We believe that HH
analysis will therefore facilitate the identiﬁcation of dis-
ease genes both for single-gene and multigene diseases.
Acknowledgments
We thank Prof. Hideshi Kawakami, Hiroshima University, Japan,
for his critical review of the manuscript, and Ms. Yukiko Yatsuka,
for her valuable technical assistance. This work was supported in
part by the following grants-in-aid: (1) for scientiﬁc research (No.
18390242) from the Japan Society for the Promotion of Science,
(2) for Comprehensive Research on Aging and Health from the
Ministry of Health, Labor, and Welfare, Japan, and (3) from the
Ministry of Education, Culture, Sports, Science, and Technology
of Japan, in particular by a Ministry Grant to the SaitamaMedical
University Research Center for Genomic Medicine.
Appendix A
Deduction of Equation (1)
The calculation to obtain is presented as anRCA(1,1)
example (ﬁg. A1). A and B are the common ancestors.m1–
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Figure A1. Deduction of equation (1). Gray circles and boxes
indicate spouses. Gray areas of the chromosomes come from
spouses and do not contain segments from the common ancestors
(i.e., A and B).
1 and m1–2 are two copies of homologous chromosomes
for subject m1, and n1–1 and n1–2 are two copies of ho-
mologous chromosomes for subject n1. One half of m1–
1 is from m0–1, and the other half is fromm0–2. One half
of n1–1 is from n0–1, and the other half is from n0–2.
Between subjects m1 and n1, the ratio of the RCA to the
entire chromosome is calculated as the probability that
m1 and n1 share the same chromosomal segment at a
speciﬁc position on chromosomes. It can be obtained by
subtracting from 1 the probability that m1–1, m1–2, n1–
1, and n1–2 all have segments derived from different chro-
mosomes. Therefore,
1 1 3
RCA(1,1)p 1 # p .
2 2 4
for other values of m and n were similarly ob-RCA(m,n)
tained and summarized in equation (1).
Calculation of False Negatives, Type A False Positives,
and Type B False Positives
Step 1: Ratio of False Negatives to Total Length of
RCAs (Rfalse negatives).—According to the Haldane’s Pois-
son model, the length (x, in centimorgans) of the chro-
mosomal segment derived from an ancestral chromosome
in generation m (see ﬁg. 2B) has an exponential distri-
bution that has the probability density function
lxf(x)p le ,
m
lp . (A1)
100
First, the union of ancestral chromosomal segments on
two homologous chromosomes are taken for each subject.
Next, the RCAs are the intersections of these unions be-
tween the two subjects. From equation A1, when m n
(see ﬁg. 2B) is large enough, for an RCHH cutoffRFalse negatives
c is approximated by
c
xf(x)dx∫
0R ≈ False negatives
xf(x)dx∫
0
lcp 1 e (1 lc) , (A2)
where
lxf(x)p le
m n
lp .
100
However, when is small, the deviatesm n RFalse negatives
from the value calculated by equation (A2). We therefore
obtained for small values of by theMonteR m nFalse negatives
Carlo method, with use of 100,000 pedigrees (table A1).
We found that equation (A2) provides good approxima-
tions when (see table A1; compare the valuesm n 1 12
for ).m np 12
Step 2: Ratio of the Type A False Positives to the Entire
Autosome (RType A false positives).—Given that is theNSNP
total number of SNPs on a genotyping chip, and andPn
are the frequencies of the major and minor alleles forQn
the nth SNP, respectively, the average frequencies of the
major alleles ( ) and the minor alleles ( )
— —
F Fmajor allele minor allele
are
NSNP Pn— np1F pmajor allele NSNP
and
NSNP Qn— np1F p ,minor allele NSNP
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Figure A2. Two strategies for comparing the patient pool with
the control pool.
respectively. The number of mismatched compSNPs
( ) is approximated byNmismatched compSNP
2 2— —( ) ( )2 F F N Nmajor allele minor allele Pt1 Pt2
N ≈ ,mismatched compSNP NSNP
where and are the numbers of SNPs successfullyN NPt1 Pt2
genotyped for Pt1 and Pt2, respectively. isNmismatched compSNP
not a large number. For example, with use of the 500k
GeneChips from Affymetrix, is 22,000 atNmismatched compSNP
maximum, spaced at 0.16 cM on average. This spacing is
larger in size than most of the haplotype blocks and thus
is assumed to be randomly distributed over the entire au-
tosome. The length between two mismatched compSNPs
is considered to have an exponential distribution with a
density probability function of
lxf(x)p le ,
Nmismatched compSNP
lp ,
Lautosome
where is the entire genetic length of the auto-Lautosome
somes. Therefore, for the cutoff value c,

xf(x)dx∫
c lc( )R p p 1 lc e .Type A false positives
xf(x)dx∫
0
Step 3: Ratio of the Type B False Positives to the Entire
Length of the Autosomes (RTypeBfalsepositives).—AnRCHH
containing an RCA is expected to have the type B false
positives with a length of on each end. It iscut off value2
impossible to distinguish RCHHs that contain the RCAs
from those that do not (i.e., the type A false positives).
We calculated under the assumption thatRType B false positives
every RCHH contains an RCA. Therefore, the
calculation results in an overestimation,RType B false positives
which we consider to be more appropriate than an un-
derestimation when the appropriate RCHH cutoff is being
determined.
The Representative
The easiest way to compare the patient pool and the
control pool is to directly compare the number of patients
sharing the RCHHs at the given position (ﬁg. A2A). This
algorithm usually works ﬁne, but actually this reduces the
sensitivity. Assume that, at a speciﬁc position, the patient
pool has 4 subjects sharing HH1 and has 0 subject sharing
HH2. The control pool has 0 subject sharing HH1 and 4
subjects sharing HH2. Although two pools are different in
their frequency of HH1, the algorithm shown in ﬁgure
A2A does not detect it.
One of the ways to solve this problem is to have a rep-
resentative, as shown in ﬁg. A2B, as we did in this study.
For the actual algorithm, please see the program source
code. This algorithm may have difﬁculty picking up the
most common HHs in a region where there is no domi-
nant HH but only many kinds of HHs with low frequen-
cies, which we think does not cause any major problems.
We have also provided the source code for an alternative
algorithm. The source may be modiﬁed according to your
uses.
Crossover Interference and the Size of the RCAs
Crossover interference increases the average size of the
RCA, and favors the RCHHs in detecting the RCA, which
reduces the false negatives. This results in a better perfor-
mance in HH analysis. Figure A3 shows an RCA in one
generation. The size of RCA may be reduced in size in the
next generation. The reduction occurs by two processes:
(1) crossover occurs in one or both subjects and (2) mul-
Table A1. Ratios of False Negatives to the Total Length of the RCAs for a Range of RCHH Cutoffs
Ratio of False Negatives to Total Length of the RCAs, by RCHH Cutoff (in cM)
Calculation
Method and
Variable(s) .2 .4 .6 .8 1 1.2 1.4 1.6 1.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6
Monte Carlo
mn m n
2 2 0 .000 .000 .000 .000 .000 .000 .000 .000 .000 .001 .001 .001 .001 .001 .001 .001 .002 .002 .002 .002 .003 .003 .003 .003 .004 .004 .004 .004 .005 .005
1 1 .000 .000 .000 .000 .000 .000 .001 .001 .001 .001 .001 .001 .002 .002 .002 .003 .003 .003 .004 .004 .004 .005 .005 .005 .006 .006 .007 .007 .008 .008
3 3 0 .000 .000 .000 .000 .000 .001 .001 .001 .001 .002 .002 .002 .003 .003 .003 .004 .004 .005 .005 .006 .007 .007 .008 .008 .009 .010 .011 .012 .012 .013
2 1 .000 .000 .000 .000 .001 .001 .001 .001 .002 .002 .003 .003 .004 .004 .005 .005 .006 .007 .008 .008 .009 .010 .011 .012 .013 .014 .015 .016 .017 .018
4 4 0 .000 .000 .000 .000 .001 .001 .001 .002 .002 .003 .003 .004 .005 .005 .006 .007 .008 .009 .010 .011 .012 .013 .014 .015 .017 .018 .019 .021 .022 .024
3 1 .000 .000 .000 .001 .001 .001 .002 .002 .003 .004 .004 .005 .006 .007 .008 .009 .010 .011 .013 .014 .015 .017 .018 .019 .021 .022 .024 .026 .028 .029
2 2 .000 .000 .000 .001 .001 .002 .002 .003 .004 .004 .005 .006 .007 .009 .010 .011 .013 .014 .015 .017 .019 .020 .022 .024 .026 .028 .030 .032 .034 .036
5 5 0 .000 .000 .000 .001 .001 .002 .002 .003 .004 .004 .005 .006 .007 .008 .010 .011 .012 .014 .015 .017 .019 .020 .022 .024 .026 .028 .030 .032 .034 .037
4 1 .000 .000 .001 .001 .001 .002 .003 .004 .004 .005 .007 .008 .009 .010 .012 .013 .015 .017 .019 .020 .022 .025 .027 .029 .031 .034 .036 .039 .041 .044
3 2 .000 .000 .001 .001 .002 .002 .003 .004 .005 .006 .008 .009 .011 .012 .014 .016 .018 .020 .022 .024 .026 .029 .031 .034 .036 .039 .042 .044 .047 .050
6 6 0 .000 .000 .001 .001 .002 .002 .003 .004 .005 .006 .008 .009 .010 .012 .014 .016 .018 .020 .022 .024 .026 .029 .031 .034 .036 .039 .041 .044 .047 .050
5 1 .000 .000 .001 .001 .002 .003 .004 .005 .006 .007 .009 .011 .013 .014 .016 .018 .020 .023 .025 .028 .030 .033 .036 .039 .042 .045 .049 .052 .056 .059
4 2 .000 .000 .001 .001 .002 .003 .004 .006 .007 .009 .010 .012 .014 .016 .018 .021 .023 .026 .029 .032 .035 .038 .041 .044 .048 .051 .055 .059 .062 .066
3 3 .000 .000 .001 .001 .002 .003 .004 .006 .007 .009 .010 .012 .014 .016 .019 .021 .024 .026 .029 .032 .035 .038 .042 .045 .048 .052 .055 .059 .063 .066
7 6 1 .000 .000 .001 .002 .003 .004 .005 .006 .008 .010 .011 .013 .016 .018 .021 .023 .026 .029 .033 .036 .040 .043 .046 .050 .054 .058 .063 .067 .071 .075
5 2 .000 .000 .001 .002 .003 .004 .006 .007 .009 .011 .013 .016 .018 .021 .024 .027 .030 .034 .037 .041 .044 .048 .052 .056 .061 .065 .070 .075 .080 .084
4 3 .000 .000 .001 .002 .003 .004 .006 .007 .009 .011 .013 .016 .018 .021 .024 .026 .030 .033 .037 .040 .044 .048 .052 .056 .061 .065 .069 .074 .078 .083
8 6 2 .000 .001 .001 .003 .004 .005 .007 .009 .012 .014 .017 .020 .023 .026 .029 .033 .037 .041 .046 .050 .055 .060 .064 .069 .075 .081 .086 .092 .097 .103
5 3 .000 .001 .001 .002 .004 .005 .007 .009 .011 .014 .017 .019 .022 .026 .029 .032 .036 .040 .045 .050 .054 .059 .063 .069 .074 .080 .085 .091 .096 .101
4 4 .000 .001 .001 .002 .004 .005 .007 .009 .011 .014 .017 .019 .022 .026 .029 .032 .036 .040 .045 .049 .054 .059 .063 .068 .073 .079 .084 .089 .094 .099
9 6 3 .000 .001 .002 .003 .005 .007 .009 .012 .015 .017 .020 .024 .027 .031 .035 .039 .044 .049 .055 .061 .067 .073 .079 .085 .092 .098 .104 .111 .117 .124
5 4 .000 .001 .002 .003 .004 .006 .009 .011 .013 .016 .019 .022 .026 .030 .034 .038 .043 .047 .052 .057 .063 .069 .074 .081 .088 .094 .100 .105 .111 .118
10 6 4 .000 .001 .002 .004 .006 .008 .011 .014 .017 .021 .024 .028 .032 .036 .041 .046 .051 .056 .062 .068 .074 .081 .090 .097 .104 .111 .119 .126 .134 .142
5 5 .000 .001 .002 .003 .005 .007 .011 .014 .016 .019 .023 .027 .031 .035 .040 .045 .051 .056 .062 .068 .074 .081 .088 .095 .102 .110 .117 .124 .131 .138
11 6 5 .000 .001 .002 .004 .007 .009 .013 .016 .019 .023 .027 .032 .037 .042 .047 .053 .060 .066 .072 .080 .089 .096 .103 .110 .117 .125 .133 .141 .150 .158
12 6 6 .000 .001 .003 .005 .008 .010 .014 .019 .023 .027 .032 .037 .042 .049 .056 .063 .069 .077 .084 .092 .101 .111 .120 .128 .137 .145 .152 .159 .166 .173
Eq. (A1)
mn m n
12 .000 .001 .002 .004 .007 .009 .013 .016 .020 .025 .029 .034 .040 .045 .051 .057 .064 .070 .077 .084 .091 .099 .106 .114 .122 .130 .138 .146 .154 .163
13 .000 .001 .003 .005 .008 .011 .015 .019 .023 .028 .034 .040 .046 .052 .059 .066 .073 .081 .088 .096 .104 .113 .121 .130 .139 .148 .157 .166 .175 .184
14 .000 .002 .003 .006 .009 .013 .017 .022 .027 .033 .039 .045 .052 .059 .067 .075 .083 .091 .100 .109 .118 .127 .137 .146 .156 .166 .175 .185 .196 .206
15 .000 .002 .004 .007 .010 .014 .019 .025 .031 .037 .044 .051 .059 .067 .075 .084 .093 .103 .112 .122 .132 .142 .152 .163 .173 .184 .195 .206 .217 .228
16 .000 .002 .004 .008 .012 .016 .022 .028 .034 .041 .049 .057 .066 .075 .084 .094 .104 .114 .125 .135 .146 .157 .168 .180 .191 .203 .214 .226 .238 .250
17 .001 .002 .005 .008 .013 .018 .024 .031 .038 .046 .055 .064 .073 .083 .093 .104 .115 .126 .137 .149 .161 .173 .185 .197 .209 .222 .234 .247 .259 .272
18 .001 .002 .005 .009 .014 .020 .027 .034 .042 .051 .060 .070 .081 .091 .103 .114 .126 .138 .150 .163 .175 .188 .201 .214 .228 .241 .254 .267 .280 .294
19 .001 .003 .006 .010 .016 .022 .030 .038 .047 .056 .066 .077 .088 .100 .112 .125 .137 .150 .163 .177 .190 .204 .218 .232 .246 .260 .274 .288 .302 .316
20 .001 .003 .007 .012 .018 .025 .033 .041 .051 .062 .073 .084 .096 .109 .122 .135 .149 .163 .177 .191 .206 .220 .235 .250 .264 .279 .294 .308 .323 .337
25 .001 .005 .010 .018 .027 .037 .049 .062 .075 .090 .106 .122 .139 .156 .173 .191 .209 .228 .246 .264 .283 .301 .319 .337 .355 .373 .391 .408 .425 .442
30 .002 .007 .014 .025 .037 .051 .067 .084 .103 .122 .142 .163 .184 .206 .228 .250 .272 .294 .316 .337 .359 .380 .401 .422 .442 .462 .482 .501 .519 .537
35 .002 .009 .019 .033 .049 .067 .087 .109 .132 .156 .180 .206 .231 .257 .283 .308 .334 .359 .384 .408 .432 .455 .478 .501 .522 .543 .563 .583 .602 .620
40 .003 .012 .025 .041 .062 .084 .109 .135 .163 .191 .220 .250 .279 .308 .337 .366 .394 .422 .449 .475 .501 .525 .549 .572 .594 .615 .636 .655 .674 .692
50 .005 .018 .037 .062 .090 .122 .156 .191 .228 .264 .301 .337 .373 .408 .442 .475 .507 .537 .566 .594 .620 .645 .669 .692 .713 .733 .751 .769 .785 .801
60 .007 .025 .051 .084 .122 .163 .206 .250 .294 .337 .380 .422 .462 .501 .537 .572 .605 .636 .665 .692 .717 .740 .762 .782 .801 .818 .834 .849 .862 .874
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Figure A3. Effects of crossover interference. Process numbers are
enclosed in the circle. Processes 1 and 2 both reduce the length
of the RCAs in the next generation. Process 1 is independent of
and process 2 is dependent on the crossover interference. Gray
area, shared segments derived from a common ancestor.
tiple crossovers occur in one or both subjects. Although
occurrence of process 2 may be suppressed by crossover
interference, process 1 is independent of the interference
and is not suppressed. Moreover, as the size of the shared
segments from the common ancestor (shown in gray in
ﬁg. A3) shortens over generations, multiple crossovers in
a single RCA become less frequent, evenwithout crossover
interference, and process 1 becomes themain determinant
of the size of the RCAs. Therefore, crossover interference
has a limited effect on HH analysis, and so we chose not
to make any adjustment in the algorithm.
Web Resources
URLs for data presented herein are as follows:
Affymetrix, http://www.affymetrix.com/index.affx
GCC, the GNU Compiler Collection, http://gcc.gnu.org/
K.H.’s Web site, http://homepage.mac.com/hagiwark/FileSharing1
.html (for HH analysis program)
International HapMap Project, http://www.hapmap.org/
National Center for Biotechnology Information,http://www.ncbi
.nlm.nih.gov/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/
Saitama Medical University, http://www.saitama-med.ac.jp/
genome/TR/hh_analysis_program_and_manual.zip (for HH
analysis program and manual)
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